Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer

Abstract Objective The current study evaluated the expression of WW domain-containing oxidoreductase (WWOX), its association with clinicopathological features and with p53, Ki-67 (cell proliferation) and CD31 (angiogenesis) expression in patients with invasive cervical squamous cell carcinoma (ICSCC). To the best of our knowledge, no other study has evaluated this association. Methods Women with IB stage-ICSCC (n = 20) and women with uterine leiomyoma (n = 20) were prospectively evaluated. Patients with ICSCC were submitted to type BC1 radical hysterectomy and pelvic lymphadenectomy. Patients in the control group underwent vaginal hysterectomy. Tissue samples were stained with hematoxylin and eosin for histological evaluation and protein expression was detected by immunohistochemistry studies. Results The WWOX expression was significantly lower in the tumor compared with the expression in thebenign cervix (p = 0.019). TheWWOXexpressionwas inversely associated with the CD31 expression in the tumor samples (p = 0.018). There was no association betweentheWWOXexpression with the p53 expression (p = 0.464)or the Ki-67expression (p = 0.360) in the samples of invasive carcinoma of the cervix. There was no association between the WWOX expression and tumor size (p = 0.156), grade of differentiation (p = 0.914), presence of lymphatic vascular invasion (p = 0.155), parametrium involvement (p = 0.421) or pelvic lymph node metastasis (p = 0.310) in ICSCC tissue samples. Conclusion The results suggested that WWOX may be involved in ICSCC carcinogenesis, and this marker was associated with tumor angiogenesis.

Saved in:
Bibliographic Details
Main Authors: Seabra,Mariana Ataydes Leite, Cândido,Eduardo Batista, Vidigal,Paula Vieira Teixeira, Lamaita,Rivia Mara, Rodrigues,Angélica Nogueira, Silva Filho,Agnaldo Lopes da
Format: Digital revista
Language:English
Published: Federação Brasileira das Sociedades de Ginecologia e Obstetrícia 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032018000200079
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0100-72032018000200079
record_format ojs
spelling oai:scielo:S0100-720320180002000792018-05-24Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical CancerSeabra,Mariana Ataydes LeiteCândido,Eduardo BatistaVidigal,Paula Vieira TeixeiraLamaita,Rivia MaraRodrigues,Angélica NogueiraSilva Filho,Agnaldo Lopes da cervical neoplasia immunohistochemistry tumor suppressor gene WWOX Abstract Objective The current study evaluated the expression of WW domain-containing oxidoreductase (WWOX), its association with clinicopathological features and with p53, Ki-67 (cell proliferation) and CD31 (angiogenesis) expression in patients with invasive cervical squamous cell carcinoma (ICSCC). To the best of our knowledge, no other study has evaluated this association. Methods Women with IB stage-ICSCC (n = 20) and women with uterine leiomyoma (n = 20) were prospectively evaluated. Patients with ICSCC were submitted to type BC1 radical hysterectomy and pelvic lymphadenectomy. Patients in the control group underwent vaginal hysterectomy. Tissue samples were stained with hematoxylin and eosin for histological evaluation and protein expression was detected by immunohistochemistry studies. Results The WWOX expression was significantly lower in the tumor compared with the expression in thebenign cervix (p = 0.019). TheWWOXexpressionwas inversely associated with the CD31 expression in the tumor samples (p = 0.018). There was no association betweentheWWOXexpression with the p53 expression (p = 0.464)or the Ki-67expression (p = 0.360) in the samples of invasive carcinoma of the cervix. There was no association between the WWOX expression and tumor size (p = 0.156), grade of differentiation (p = 0.914), presence of lymphatic vascular invasion (p = 0.155), parametrium involvement (p = 0.421) or pelvic lymph node metastasis (p = 0.310) in ICSCC tissue samples. Conclusion The results suggested that WWOX may be involved in ICSCC carcinogenesis, and this marker was associated with tumor angiogenesis.info:eu-repo/semantics/openAccessFederação Brasileira das Sociedades de Ginecologia e ObstetríciaRevista Brasileira de Ginecologia e Obstetrícia v.40 n.2 20182018-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032018000200079en10.1055/s-0037-1618597
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Seabra,Mariana Ataydes Leite
Cândido,Eduardo Batista
Vidigal,Paula Vieira Teixeira
Lamaita,Rivia Mara
Rodrigues,Angélica Nogueira
Silva Filho,Agnaldo Lopes da
spellingShingle Seabra,Mariana Ataydes Leite
Cândido,Eduardo Batista
Vidigal,Paula Vieira Teixeira
Lamaita,Rivia Mara
Rodrigues,Angélica Nogueira
Silva Filho,Agnaldo Lopes da
Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
author_facet Seabra,Mariana Ataydes Leite
Cândido,Eduardo Batista
Vidigal,Paula Vieira Teixeira
Lamaita,Rivia Mara
Rodrigues,Angélica Nogueira
Silva Filho,Agnaldo Lopes da
author_sort Seabra,Mariana Ataydes Leite
title Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
title_short Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
title_full Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
title_fullStr Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
title_full_unstemmed Immunohistochemical WWOX Expression and Association with Angiogenesis, p53 Expression, Cell Proliferation and Clinicopathological Parameters in Cervical Cancer
title_sort immunohistochemical wwox expression and association with angiogenesis, p53 expression, cell proliferation and clinicopathological parameters in cervical cancer
description Abstract Objective The current study evaluated the expression of WW domain-containing oxidoreductase (WWOX), its association with clinicopathological features and with p53, Ki-67 (cell proliferation) and CD31 (angiogenesis) expression in patients with invasive cervical squamous cell carcinoma (ICSCC). To the best of our knowledge, no other study has evaluated this association. Methods Women with IB stage-ICSCC (n = 20) and women with uterine leiomyoma (n = 20) were prospectively evaluated. Patients with ICSCC were submitted to type BC1 radical hysterectomy and pelvic lymphadenectomy. Patients in the control group underwent vaginal hysterectomy. Tissue samples were stained with hematoxylin and eosin for histological evaluation and protein expression was detected by immunohistochemistry studies. Results The WWOX expression was significantly lower in the tumor compared with the expression in thebenign cervix (p = 0.019). TheWWOXexpressionwas inversely associated with the CD31 expression in the tumor samples (p = 0.018). There was no association betweentheWWOXexpression with the p53 expression (p = 0.464)or the Ki-67expression (p = 0.360) in the samples of invasive carcinoma of the cervix. There was no association between the WWOX expression and tumor size (p = 0.156), grade of differentiation (p = 0.914), presence of lymphatic vascular invasion (p = 0.155), parametrium involvement (p = 0.421) or pelvic lymph node metastasis (p = 0.310) in ICSCC tissue samples. Conclusion The results suggested that WWOX may be involved in ICSCC carcinogenesis, and this marker was associated with tumor angiogenesis.
publisher Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032018000200079
work_keys_str_mv AT seabramarianaataydesleite immunohistochemicalwwoxexpressionandassociationwithangiogenesisp53expressioncellproliferationandclinicopathologicalparametersincervicalcancer
AT candidoeduardobatista immunohistochemicalwwoxexpressionandassociationwithangiogenesisp53expressioncellproliferationandclinicopathologicalparametersincervicalcancer
AT vidigalpaulavieirateixeira immunohistochemicalwwoxexpressionandassociationwithangiogenesisp53expressioncellproliferationandclinicopathologicalparametersincervicalcancer
AT lamaitariviamara immunohistochemicalwwoxexpressionandassociationwithangiogenesisp53expressioncellproliferationandclinicopathologicalparametersincervicalcancer
AT rodriguesangelicanogueira immunohistochemicalwwoxexpressionandassociationwithangiogenesisp53expressioncellproliferationandclinicopathologicalparametersincervicalcancer
AT silvafilhoagnaldolopesda immunohistochemicalwwoxexpressionandassociationwithangiogenesisp53expressioncellproliferationandclinicopathologicalparametersincervicalcancer
_version_ 1756389779140771840